Connect
← Return to New study: Early treatment with interferon can delay myelofibrosis
Discussion
New study: Early treatment with interferon can delay myelofibrosis
Blood Cancers & Disorders | Last Active: 10 minutes ago | Replies (13)Comment receiving replies
@nohrt4me Thanks you so much for your response 🙏. I was assuming that for example Ropeginterferon has less sideeffects. Do you know more about it and have you ever taken those meds by yourself ( sorry for my low level of English I am living in Germany 😅)
Replies to "@nohrt4me Thanks you so much for your response 🙏. I was assuming that for example Ropeginterferon..."
Connect
@birgitr No, I have not taken any of the interferons. In talking with other ET patients, it seems that ropeginterferon has fewer side effects than Pegasys. Older people (over age 60) often stopped Pegasys because it caused depression. Those currently taking Besremi (ropeginterferon), seem to be doing well with it. In some parts of Europe, the standard protocol was for those under age 40 to receive interferon, which does not cause birth defects, and for those between 40 and 60 to have a choice between interferon and hydroxyurea. Those over age 60 were usually steered toward hydroxyurea. But since Besremi became available, that may have changed. Is it more widely available in Germany?